POSTERS
NetraAI: Understanding Patient Populations Beyond Disease Labels for De-Risking Clinical Trials with Large Language Models
Uncovering an Association Between Oligodendroglioma and the Human Papillomavirus (HPV) Through Molecular Subpopulation Analysis Using NetraAI
Understanding treatment response in pancreatic cancer: NetraAI provides genetic differentiation in FOLFIRINOX and Gemcitabine response
Using AI on Data from Anxiety and Schizophrenia Trials to Identify Causal Clusters of Variables for Drug & Placebo Response Via Long Range Memory to Improve Clinical Trial Outcomes
Using NetraAI Hypothesis-Generation for Patient Stratification and Target Discovery in ALS
